author-photo

Ronit Simantov

Center for Global Development

3

Papers

139

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (68)
A phase I dose escalation study of OSI-906 in patients with advanced solid tumours

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)